Cells exhibiting high expression of BCAN, GFAP, and EGFR were categorized as cancer cells, while endothelial cells displayed elevated levels of FLT1, CLDN5, and ABCG2 (Figure 1C). This evidence concerns the gene CLDN5 and cancer.